Retatrutide (also designated LY3437943) is a synthetic, investigational-grade peptide engineered as a unimolecular triple agonist targeting three key metabolic receptors simultaneously: the glucagon-like peptide-1 receptor (GLP-1R), the glucose-dependent insulinotropic polypeptide receptor (GIPR), and the glucagon receptor (GcgR)
The addition of 2-DG blocks biochemical pathways that reduce NADP + to NADPH in LPS-stimulated cells
NewsHealth8 January 2026, 3:34pmKilos return four times faster after ending weight-loss drugs, study findsPhoto credit:Unsplash / Getty ImagesWeight-loss drugs like Ozempic and Wegovy have become immensely popular.NewsHealth8 January 2026, 3:34pm
Metabolic health beyond weight Effects on cardiovascular outcomes, fatty liver, metabolic syndrome
Gut Microbes 12:1714401 Tanno M, Sakamoto J, Miura T, Shimamoto K, Horio Y (2007) Nucleocytoplasmic shuttling of the NAD+-dependent histone deacetylase SIRT1
This mechanistic difference suggests the potential for additive effects without direct pharmacological overlap